republic-os/legal/us/code/title-42/chapter-6a/section-285a-11a.md

type, title, description, jurisdiction, corpus, kind, title_number, title_name, chapter_number, chapter_name, section, citation, status, release_point, release_date, source, source_url, source_identifier, source_file, source_hash, raw_snapshot_hash, text_hash, retrieved_at, confidence, tags

type	title	description	jurisdiction	corpus	kind	title_number	title_name	chapter_number	chapter_name	section	citation	status	release_point	release_date	source	source_url	source_identifier	source_file	source_hash	raw_snapshot_hash	text_hash	retrieved_at	confidence	tags
LegalText	42 U.S.C. § 285a–11a	Cancer survivorship programs	us	united_states_code	code_section	42	THE PUBLIC HEALTH AND WELFARE	6A	PUBLIC HEALTH SERVICE	285a–11a	42 U.S.C. § 285a–11a	current	119-100	2026-06-26	official	https://uscode.house.gov/download/releasepoints/us/pl/119/100/xml_usc42@119-100.zip	/us/usc/t42/s285a–11a	data/legal/raw/us/code/title-42/usc42.xml	8e705698ad26d96e1447340dd6cdc1275e712356aacb4fe7000e2e30dc36cdbd	644321055a08eb1f260a6a3e31ac157fa024756abf612a9fd6857e7e400cf24e	99611588aea984d0fe92f78e4c4ade8987f7d098fb4dc2b3246b0004c1bb254f	2026-07-04	official	legal us-code

42 U.S.C. § 285a–11a - Cancer survivorship programs

Text

(a) Research to evaluate model systems of care for pediatric cancer survivors (1) In general The Secretary of Health and Human Services (referred to in this section as the “Secretary”) shall, as appropriate, make awards to eligible entities to conduct or support research to develop, study, or evaluate approaches for monitoring and caring for childhood and adolescent cancer survivors throughout their lifespan, including transition to adult care and care coordination.

(2) Awards (A) Types of entities In making awards under this subsection, the Secretary shall, to the extent practicable, within the existing peer review process, include—

(i) small, medium, and large-sized eligible entities; and

(ii) sites located in different geographic areas, including rural and urban areas.

(B) Eligible entities In this subsection, the term “eligible entity” means—

(i) a medical school;

(ii) a children’s hospital;

(iii) a cancer center;

(iv) a community-based medical facility; or

(v) any other entity with significant experience and expertise in carrying out the activities described in paragraph (1).

(3) Use of funds Funds awarded under this subsection may be used—

(A) to develop, study, or evaluate one or more models for monitoring and caring for cancer survivors; and

(B) in developing, studying, and evaluating such models, to give special emphasis to—

(i) design of models of follow-up care, monitoring, and other survivorship programs (including peer support and mentoring programs);

(ii) development of models for providing multidisciplinary care;

(iii) dissemination of information to health care providers about culturally and linguistically appropriate follow-up care for cancer survivors and their families, as appropriate and practicable;

(iv) development of psychosocial and support programs to improve the quality of life of cancer survivors and their families, which may include peer support and mentoring programs;

(v) design tools to support the secure electronic transfer of treatment information and care summaries between health care providers or, as applicable and appropriate, longitudinal childhood cancer survivorship cohorts (including risk factors and a plan for recommended follow-up care);

(vi) dissemination of the information and programs described in clauses (i) through (v) to other health care providers (including primary care physicians and internists) and to cancer survivors and their families, where appropriate and in accordance with Federal and State law; and

(vii) development of initiatives that promote the coordination and effective transition of care between cancer care providers, primary care physicians, mental health professionals, and other health care professionals, as appropriate, including models that use a team-based or multi-disciplinary approach to care.

(b) Workforce development for health care providers on medical and psychosocial care for childhood cancer survivors (1) In general The Secretary shall, not later than 1 year after January 5, 2023, conduct a review of the activities of the Department of Health and Human Services related to workforce development for health care providers who treat pediatric cancer patients and survivors. Such review shall include—

(A) identification of existing models relevant to providing medical and psychosocial services to individuals surviving pediatric cancers, and programs related to training for health professionals who provide such services to individuals surviving pediatric cancers; and

(B) recommendations for enhancing or promoting activities of the Department of Health and Human Services related to workforce development for health care providers who provide psychosocial care to pediatric cancer patients and survivors.

(2) Report Not later than 2 years after January 5, 2023, the Secretary shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and Committee on Energy and Commerce of the House of Representatives, a report concerning the findings and recommendations from the review conducted under paragraph (1).

(Pub. L. 115–180, title II, § 201, June 5, 2018, 132 Stat. 1387; Pub. L. 117–350, § 2(b), Jan. 5, 2023, 136 Stat. 6263.)

Notes

Editorial Notes

Codification Section was enacted as part of the Childhood Cancer Survivorship, Treatment, Access, and Research Act of 2018, also known as the Childhood Cancer STAR Act, and not as part of the Public Health Service Act which comprises this chapter.

Amendments2023—Subsec. (a). Pub. L. 117–350, § 2(b)(1)(A), substituted “Research to evaluate” for “Pilot programs to explore” in heading. Subsec. (a)(1). Pub. L. 117–350, § 2(b)(1)(B), substituted “shall, as appropriate, make awards to eligible entities to conduct or support research” for “may make awards to eligible entities to establish pilot programs” and “approaches” for “model systems”, inserted “and adolescent” after “childhood”, and struck out “evaluation of models for” before “transition”. Subsec. (a)(2)(A). Pub. L. 117–350, § 2(b)(1)(C)(i), inserted “within the existing peer review process,” after “practicable,” in introductory provisions. Subsec. (a)(2)(B)(v). Pub. L. 117–350, § 2(b)(1)(C)(ii), substituted “in carrying out the activities described in paragraph (1)” for “in treating survivors of childhood cancers”. Subsec. (a)(3)(B)(v). Pub. L. 117–350, § 2(b)(1)(D), substituted “design tools to support the secure electronic transfer of treatment information and care summaries between health care providers or, as applicable and appropriate, longitudinal childhood cancer survivorship cohorts” for “design of systems for the effective transfer of treatment information and care summaries from cancer care providers to other health care providers”. Subsec. (b)(1). Pub. L. 117–350, § 2(b)(2)(A), substituted “January 5, 2023” for “June 5, 2018” in introductory provisions. Subsec. (b)(1)(A) to (C). Pub. L. 117–350, § 2(b)(2)(B), added subpar. (B), redesignated former subpar. (B) as (A), and struck out former subpars. (A) and (C) which read as follows: “(A) an assessment of the effectiveness of supportive psychosocial care services for pediatric cancer patients and survivors, including pediatric cancer survivorship care patient navigators and peer support programs; “(C) recommendations for improving the provision of psychosocial care for pediatric cancer survivors and patients.” Subsec. (b)(2). Pub. L. 117–350, § 2(b)(2)(A), substituted “January 5, 2023” for “June 5, 2018”.